{"brief_title": "Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes", "brief_summary": "This trial is conducted in the United States of America (USA). The purpose of this study is to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to regular human insulin for the control of blood glucose after meals in women who develop diabetes during pregnancy.", "condition": ["Diabetes", "Gestational Diabetes"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["human insulin", "insulin NPH", "insulin aspart"], "criteria": "Inclusion Criteria: - Subjects older than 35 years old will be considered - Gestational diabetes mellitus", "gender": "Female", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "Accepts Healthy Volunteers", "mesh_term": ["Diabetes Mellitus", "Diabetes, Gestational", "Insulin, Globin Zinc", "Insulin degludec, insulin aspart drug combination", "Isophane insulin, beef", "Insulin", "Insulin Aspart", "Insulin, Long-Acting", "Isophane Insulin, Human", "Insulin, Isophane"], "id": "NCT00065130"}